Abstract
Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Current Organic Chemistry
Title: The Daphniphyllum Alkaloids
Volume: 13 Issue: 6
Author(s): Mei Dong, Man-Li Zhang, Qing-Wen Shi, Yu-Cheng Gu and Hiromasa Kiyota
Affiliation:
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Abstract: Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Export Options
About this article
Cite this article as:
Dong Mei, Zhang Man-Li, Shi Qing-Wen, Gu Yu-Cheng and Kiyota Hiromasa, The Daphniphyllum Alkaloids, Current Organic Chemistry 2009; 13 (6) . https://dx.doi.org/10.2174/138527209787847345
DOI https://dx.doi.org/10.2174/138527209787847345 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Increased Expression of IRE1α Associates with the Resistant Mechanism of Osimertinib (AZD9291)-resistant non-small Cell Lung Cancer HCC827/OSIR Cells
Anti-Cancer Agents in Medicinal Chemistry Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma
Anti-Cancer Agents in Medicinal Chemistry Microbubble-Assisted p53, RB, and p130 Gene Transfer in Combination with Radiation Therapy in Prostate Cancer
Current Gene Therapy Antitumor Activity of Copper (I)–Nicotinate Complex and Autophagy Modulation in HCC1806 Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System
Current Drug Targets Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry Efficacy and Toxicological Studies of Cremophor EL Free Alternative Paclitaxel Formulation
Current Drug Safety Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Evaluation of Adhesion Force and Binding Affinity of Phytohemagglutinin Erythroagglutinating to EGF Receptor on Human Lung Cancer Cells
Current Medicinal Chemistry Hybrid SPECT/CT Imaging in Neurology
Current Radiopharmaceuticals Mini-Review: Bmx Kinase Inhibitors for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Drug-Lipid Membrane Interaction Mechanisms Revealed Through Molecular Simulations
Current Physical Chemistry Biomarkers in Molecularly Targeted Therapy for Cancer
Recent Patents on Biomarkers A Critical Transcription Factor NF-κB as a Cancer Therapeutic Target and its Inhibitors as Cancer Treatment Options
Current Medicinal Chemistry The Upshot of PI3K Inhibitors as Anticancer Arsenal: A Short Review
Current Bioactive Compounds Oridonin, a Promising Antitumor Natural Product in the Chemotherapy of Hematological Malignancies
Current Pharmaceutical Biotechnology Bone Target Radiotracers for Palliative Therapy of Bone Metastases
Current Medicinal Chemistry Studies of p53 Tumor Suppression Activity in Mouse Models
Current Genomics The Fate of Nanoparticles In Vivo and the Strategy of Designing Stealth Nanoparticle for Drug Delivery
Current Drug Targets Editorial (Thematic Issue: Elderly Cancer Patients in the 3rd Millenium: Between Hope and Reality. Introduction)
Anti-Cancer Agents in Medicinal Chemistry